Literature DB >> 16043762

Prevalence of body iron excess in the metabolic syndrome.

Claudia Bozzini1, Domenico Girelli, Oliviero Olivieri, Nicola Martinelli, Antonella Bassi, Giovanna De Matteis, Ilaria Tenuti, Valentina Lotto, Simonetta Friso, Francesca Pizzolo, Roberto Corrocher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16043762     DOI： 10.2337/diacare.28.8.2061

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  61 in total

1.  Nonalcoholic fatty liver disease and HFE gene mutations: a Polish study.

Authors:  Joanna Raszeja-Wyszomirska; Grzegorz Kurzawski; Malgorzata Lawniczak; Joanna Miezynska-Kurtycz; Jan Lubinski
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

2.  Iron deposits and dietary patterns in familial combined hyperlipidemia and familial hypertriglyceridemia.

Authors:  Rocio Mateo-Gallego; Maria Solanas-Barca; Elena Burillo; Ana Cenarro; Iva Marques-Lopes; Fernando Civeira
Journal:  J Physiol Biochem       Date:  2010-07-20       Impact factor: 4.158

3.  Hepcidin response to acute iron intake and chronic iron loading in dysmetabolic iron overload syndrome.

Authors:  Paola Trombini; Valentina Paolini; Sara Pelucchi; Raffaella Mariani; Elizabeta Nemeth; Tomas Ganz; Alberto Piperno
Journal:  Liver Int       Date:  2011-04-18       Impact factor: 5.828

4.  Iron Overload Coordinately Promotes Ferritin Expression and Fat Accumulation in Caenorhabditis elegans.

Authors:  Haizhen Wang; Xue Jiang; Jieyu Wu; Linqiang Zhang; Jingfei Huang; Yuru Zhang; Xiaoju Zou; Bin Liang
Journal:  Genetics       Date:  2016-03-26       Impact factor: 4.562

Review 5.  Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.

Authors:  Luca Valenti; Paola Dongiovanni; Silvia Fargion
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

6.  Risk Factors for Insulin Resistance, Metabolic Syndrome, and Diabetes in 248 HFE C282Y Homozygotes Identified by Population Screening in the HEIRS Study.

Authors:  James C Barton; J Clayborn Barton; Paul C Adams; Ronald T Acton
Journal:  Metab Syndr Relat Disord       Date:  2016-01-15       Impact factor: 1.894

7.  Noninvasive liver-iron measurements with a room-temperature susceptometer.

Authors:  William F Avrin; Sankaran Kumar
Journal:  Physiol Meas       Date:  2007-03-07       Impact factor: 2.833

8.  Serum ferritin levels lack diagnostic accuracy for liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Paul Angulo; Jacob George; Christopher P Day; Ester Vanni; Lee Russell; Anna C De la Cruz; Hammad Liaquat; Lavinia Mezzabotta; Eun Lee; Elisabetta Bugianesi
Journal:  Clin Gastroenterol Hepatol       Date:  2013-12-14       Impact factor: 11.382

9.  The interplay among iron metabolism, endothelium and inflammatory cascade in dysmetabolic disorders.

Authors:  Z A Yegin; Ö T İyidir; C Demirtaş; E Suyanı; İ Yetkin; H Paşaoğlu; Ç İlhan; G T Sucak
Journal:  J Endocrinol Invest       Date:  2014-09-23       Impact factor: 4.256

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.